Observer variation in the diagnosis of superficial oesophageal adenocarcinoma

被引:148
作者
Ormsby, AH
Petras, RE
Henricks, WH
Rice, TW
Rybicki, LA
Richter, JE
Goldblum, JR
机构
[1] Cleveland Clin Fdn, Dept Pathol Anat, Cleveland, OH 44195 USA
[2] Henry Ford Hlth Syst, Dept Pathol Anat, Detroit, MI USA
[3] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA
[4] Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA
[5] Cleveland Clin Fdn, Ctr Swallowing & Esophageal Dis, Cleveland, OH 44195 USA
[6] Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA
关键词
D O I
10.1136/gut.51.5.671
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: When to perform oesophagectomy for neoplastic progression in Barrett's oesophagus is controversial. Some resect for high grade dysplasia whereas others defer treatment until intramucosal adenocarcinoma is diagnosed. Interobserver agreement for a diagnosis of high grade dysplasia or intramucosal adenocarcinoma remains unknown and may have therapeutic implications. Methods: Histological slides from 75 oesophagectomy specimens with high grade dysplasia or T-1 adenocarcinoma were blindly reviewed by two gastrointestinal pathologists and one general surgical pathologist, and classified as high grade dysplasia, intramucosal adenocarcinoma, or submucosal adenocarcinoma. A subsequent re-review of all 75 cases by the same observers following establishment of uniform histological criteria was undertaken. Interobserver agreement was determined. by kappa statistics. Coefficients <0.21, 0.21-0.40, 0.41-0.60, 0.61-0.80, and >0.80 were considered poor, fair, moderate, good, and very good agreement, respectively. Results: Interobserver agreement among all pathologists and between gastrointestinal pathologists when comparing high grade dysplasia with intramucosal adenocarcinoma was only fair (k=0.42; 0.56, respectively) and did not substantially improve on subsequent re-evaluation following establishment of uniform histological criteria (K=0.50; 0.61, respectively). Conclusions: When evaluating resection specimens and after implementation of uniform histological criteria, even experienced gastrointestinal pathologists frequently disagree on a diagnosis of high grade dysplasia versus intramucosal adenocarcinoma. Treatment strategies based on the histological distinction of high grade dysplasia from intramucosal adenocarcinoma using limited biopsy specimens should be re-evaluated.
引用
收藏
页码:671 / 676
页数:6
相关论文
共 36 条
[21]  
2-M
[22]   p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction [J].
Moskaluk, CA ;
Heitmiller, R ;
Zahurak, M ;
Schwab, D ;
Sidransky, D ;
Hamilton, SR .
HUMAN PATHOLOGY, 1996, 27 (11) :1211-1220
[23]  
MULLICK T, 2001, AM J GASTROENTEROL, V75, pS25
[24]   WHAT IS THE IDEAL TREATMENT FOR EARLY ESOPHAGEAL CANCER [J].
NABEYA, K ;
HANAOKA, T ;
LI, S ;
NYUMURA, T .
ENDOSCOPY, 1993, 25 (09) :670-671
[25]   BARRETT-ESOPHAGUS WITH HIGH-GRADE DYSPLASIA - AN INDICATION FOR ESOPHAGECTOMY [J].
PERA, M ;
TRASTEK, VF ;
CARPENTER, HA ;
ALLEN, MS ;
DESCHAMPS, C ;
PAIROLERO, PC .
ANNALS OF THORACIC SURGERY, 1992, 54 (02) :199-211
[26]   Epithelial cell proliferative activity of Barrett's esophagus - Methodology and correlation with traditional cancer risk markers [J].
Peters, FTM ;
Ganesh, S ;
Kuipers, EJ ;
De Jager-Krikken, A ;
Karrenbeld, A ;
Harms, G ;
Sluiter, WJ ;
Koudstaal, J ;
Klinkenberg-Knol, EC ;
Lamers, CBHW ;
Kleibeuker, JH .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (07) :1501-1506
[27]   THE VALUE OF P53 AND KI67 AS MARKERS FOR TUMOR PROGRESSION IN THE BARRETTS DYSPLASIA-CARCINOMA SEQUENCE [J].
POLKOWSKI, W ;
VANLANSCHOT, JJB ;
TENKATE, FJW ;
BAAK, JPA ;
TYTGAT, GNJ ;
OBERTOP, H ;
VOORN, WJ ;
OFFERHAUS, GJA .
SURGICAL ONCOLOGY-OXFORD, 1995, 4 (03) :163-171
[28]   Predictors of progression in Barrett's esophagus III: Baseline flow cytometric variables [J].
Rabinovitch, PS ;
Longton, G ;
Blount, PL ;
Levine, DS ;
Reid, BJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (11) :3071-3083
[29]   OBSERVER VARIATION IN THE DIAGNOSIS OF DYSPLASIA IN BARRETTS ESOPHAGUS [J].
REID, BJ ;
HAGGITT, RC ;
RUBIN, CE ;
ROTH, G ;
SURAWICZ, CM ;
VANBELLE, G ;
LEWIN, K ;
WEINSTEIN, WM ;
ANTONIOLI, DA ;
GOLDMAN, H ;
MACDONALD, W ;
OWEN, D .
HUMAN PATHOLOGY, 1988, 19 (02) :166-178
[30]   ENDOSCOPIC BIOPSY CAN DETECT HIGH-GRADE DYSPLASIA OR EARLY ADENOCARCINOMA IN BARRETTS ESOPHAGUS WITHOUT GROSSLY RECOGNIZABLE NEOPLASTIC LESIONS [J].
REID, BJ ;
WEINSTEIN, WM ;
LEWIN, KJ ;
HAGGITT, RC ;
VANDEVENTER, G ;
DENBESTEN, L ;
RUBIN, CE .
GASTROENTEROLOGY, 1988, 94 (01) :81-90